フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
GlycoGenesys, Inc., (NASDAQ: GLGS), a biotechnology company focused on carbohydrate-based drug development, provided a corporate update on its...
GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company focused on carbohydrate-based drug development, today announced that Nasdaq notified the...
? New Discovery Revealed At The 9th International Conference On Malignant Lymphoma in Lugano, Switzerland ? GlycoGenesys, Inc. (Nasdaq: GLGS...
GlycoGenesys, Inc. (Nasdaq: GLGS), a biotechnology company focused on carbohydrate-based drug development, today announced that Dr. Finbarr...
GlycoGenesys, Inc., (Nasdaq: GLGS), a biotechnology company developing carbohydrate-based drugs, today announced that the U.S. Patent and...
GlycoGenesys, Inc., (Nasdaq: GLGS), a biotechnology company developing carbohydrate-based drugs, today announced that the proposal to approve the...
Scimitar Equity Research Issues Review of GlycoGenesys, Inc. BOSTON, May 4 /PRNewswire/ -- Scimitar Equity Research, Inc. issues a review of...
GlycoGenesys, Inc., (NASDAQ:GLGS), a biotechnology company focused on carbohydrate-based drug development, announced today that John W. Burns...
Webcast Alert: GlycoGenesys, Inc. (GLGS) Presentation At RedChip Resources and Moors & Cabot's Small-Cap Investor Conference BOSTON, March 1...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す